stock

Illumina Inc (ILMN)

0

Share

Stay up to date

Illumina is improving human health by unlocking the power of the genome. Its focus on innovation has established it as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The Company products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

Financial Statements

Key Info

  • Industry: Analytical Laboratory Instrument Manufacturing
  • Sector: Manufacturing
  • CEO Name: Francis deSouza

Key Statistics

  • Stock Price: $457.16
  • Dividend Yield: 0%
  • Market Capitalization: $67,041,900,000
  • Shares Outstanding: 146,700,000
  • Number of Employees: 7,825
  • Trailing 12-Month EPS: $5.21
  • Trailing 12-Month DPS: $0
  • Payout Ratio: 0.0%

Important Dates

  • Next Earnings Date: 2021-10-28
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $457.16
  • 52-week high: $555.77
  • 52-week low: $260.42
  • 200-day moving average: $439.39
  • 50-day moving average: $490.15

Performance

  • 1-Month Price Return: -7.8%
  • 3-Month Price Return: 12.7%
  • 6-Month Price Return: 4.0%
  • 1-Year Price Return: 29.1%
  • 2-Year Price Return: 62.4%
  • 5-Year Price Return: 170.4%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast